Business
Eli Lilly Revenue Jumps 48% on Obesity Drug Sales
Second-quarter revenue reached $22.97bn and adjusted earnings beat consensus by $2.37 a share, as Mounjaro sales rose 91% and the company lifted its outlook.
Tag: Eli Lilly